Related Experiment Video
Updated: Jan 27, 2026

In Situ Measurement of Vacuum Window Birefringence using 25Mg+ Fluorescence
Published on: June 13, 2020
Mapping Patient-Reported Outcomes Measurement Information System Pediatric-25 Profile to EQ-5D-Y-3L
Renee Jones1, Christine Mpundu-Kaambwa2, Nancy Devlin2
1Melbourne Health Economics, University of Melbourne, Victoria, Australia; Health Services and Economics, Murdoch Children's Research Institute, Victoria, Australia.
Objectives:
This study aimed to generate mapping algorithms from the Patient-Reported Outcomes Measurement Information System Pediatric-25 Profile (PROMIS-25) to both EQ-5D-Y-3L responses (indirect mapping) and EQ-5D-Y-3L utilities (direct mapping).
Methods:
A subset of data from the Australian Paediatric Multi-Instrument Comparison study data set was used, including participants aged 5 to 18 years who completed both the EQ-5D-Y-3L and PROMIS-25 (n = 1830). Both direct and indirect mapping approaches were used, exploring a range of regression models and predictor variables for each approach. For the direct mapping approach, the EQ-5D-Y-3L Australian value set was used, and sensitivity analyses were conducted using the EQ-5D-Y-3L Dutch value set. Five-fold internal cross-validation was used to select the optimal mapping models based on goodness-of-fit indicators, including the root mean square error (RMSE), mean absolute error (MAE), and concordance correlation coefficient. The final mapping algorithms reported are based on the full sample.
Results:
The generalized ordered logit model using the PROMIS-25 raw domain scores as predictors was selected for predicting EQ-5D-Y-3L responses in the indirect mapping (RMSE, 0.1098; MAE, 0.0724). The Tobit model, also using the PROMIS-25 raw item scores as predictors, was the optimal direct mapping model for predicting Australian EQ-5D-Y-3L utilities (RMSE, 0.0994; MAE, 0.0712). The same models performed similarly well in sensitivity analyses using Dutch utilities.
Conclusions:
The mapping algorithms provide a pathway for PROMIS-25 data to be converted directly to either an Australian or Dutch EQ-5D-Y-3L utility or EQ-5D-Y-3L responses where local value sets can be applied. This broadens the usability of PROMIS-25, enabling calculation of utilities for use in economic evaluation.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Data Reporting and Recording
Predicting Reaction Outcomes

